top of page
.png)
InformAI News
InformAI Receives FDA 510(k) Clearance for RadOncAI Radiation Therapy Dose Planning Software
Houston, Texas – 6/25/2026 – InformAI, Inc., a leader in innovative medical technology, is proud to announce that it has received 510(k) approval from the U.S. Food and Drug Administration (FDA) to market an AI-enabled radiation therapy dose planning software, RadOncAI. This clinician co-pilot software-as-a-medical-device uses artificial intelligence (AI) to optimize the key step in radiation dose planning for head & neck cancer patients. RadOncAI enables AI-driven radiation
2 days ago
bottom of page